These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5776006)

  • 1. Experimental canine cholera. 3. Serologic studies and re-challenge experiments.
    Sack RB; Carpenter CC
    J Infect Dis; 1969 Feb; 119(2):158-64. PubMed ID: 5776006
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae.
    Sack RB; Carpenter CC
    J Infect Dis; 1969 Feb; 119(2):150-7. PubMed ID: 5776005
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae.
    Neoh SH; Rowley D
    J Infect Dis; 1972 Jul; 126(1):41-7. PubMed ID: 5038023
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of vibriocidal antibodies with regard to immunity to cholera.
    Gangarosa EJ; DeWitt WE; Feeley JC; Adams MR
    J Infect Dis; 1970 May; 121():Suppl 121:36+. PubMed ID: 4912071
    [No Abstract]   [Full Text] [Related]  

  • 5. Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.
    Hochstein HD; Feeley JC; DeWitt WE
    Appl Microbiol; 1970 May; 19(5):742-5. PubMed ID: 5463574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental canine cholera. IV. The chronic carrier state for Vibrio cholerae.
    Sack RB; Carpenter CC; Yardley JH; Subong AE
    J Infect Dis; 1969 Feb; 119(2):165-71. PubMed ID: 5776007
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of agglutinating and vibriocidal antibodies to 2-mercaptoethanol in human cholera.
    Merritt CB; Sack RB
    J Infect Dis; 1970 May; 121():Suppl 121:25+. PubMed ID: 4912070
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitoxic immunity in experimental canine cholera.
    Curlin GT; Craig JP; Subong A; Carpenter CC
    J Infect Dis; 1970 May; 121(5):463-70. PubMed ID: 5420315
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the cholera toxin and antitoxin.
    Ungar J; Stanić M; Varallyay SJ; Chariatte N
    Prog Immunobiol Stand; 1970; 4():583-9. PubMed ID: 4099025
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies of cholera cerisis inhibiting factor. 1. Isolation and specificity of the active substances from the small intestine of rabbits immunized with inactivated Vibrio cholerae].
    Morimoto T; Yamamoto M; Maruyama S; Turumizu T; Matsui S
    Yakugaku Zasshi; 1971 Dec; 91(12):1354-61. PubMed ID: 5004220
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitoxic immunity in experimental canine cholera.
    Curlin GT; Subong A; Craig JP; Carpenter CC
    Trans Assoc Am Physicians; 1968; 81():314-22. PubMed ID: 5721407
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental cholera in infant mice: protective effects of antibody.
    Chaicumpa W; Rowley D
    J Infect Dis; 1972 May; 125(5):480-5. PubMed ID: 5023642
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection against experimental cholera by antitoxin.
    Pierce NF; Kaniecki EA; Northrup RS
    J Infect Dis; 1972 Dec; 126(6):606-16. PubMed ID: 4664117
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics of the serum vibriocidal and agglutinating antibodies in cholera cases and in normal residents of the endemic and non-endemic cholera areas.
    Ahmed A; Bhattacharjee AK; Mosley WH
    J Immunol; 1970 Aug; 105(2):431-41. PubMed ID: 5433700
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental canine cholera. I. Development of the model.
    Sack RB; Carpenter CC
    J Infect Dis; 1969 Feb; 119(2):138-49. PubMed ID: 5776004
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnitude and duration of antitoxic response to human infection with Vibrio cholerae.
    Pierce NF; Banwell JG; Sack RB; Mitra RC; Mondal A
    J Infect Dis; 1970 May; 121():Suppl 121:31+. PubMed ID: 5421427
    [No Abstract]   [Full Text] [Related]  

  • 17. Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease.
    Sack RB; Gorbach SL; Banwell JG; Jacobs B; Chatterjee BD; Mitra RC
    J Infect Dis; 1971 Apr; 123(4):378-85. PubMed ID: 4938945
    [No Abstract]   [Full Text] [Related]  

  • 18. Vibriocidal activity, immune globulin producing cells and immune globulin levels in Theropithecus gelada after administration of a vibrio cholerae antigen.
    Felsenfeld O; Greer WE
    Immunology; 1968 Mar; 14(3):319-24. PubMed ID: 4170509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vibriocidal antibody in clinical cholera.
    McCormack WM; Chakraborty J; Rahman AS; Mosley WH
    J Infect Dis; 1969 Aug; 120(2):192-201. PubMed ID: 5387567
    [No Abstract]   [Full Text] [Related]  

  • 20. The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    J Infect Dis; 1970 May; 121(5):505-13. PubMed ID: 4986889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.